Remove Insurance Remove Magazine Remove Vaccines
article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for continued development and distribution in low and middle-income nations. Can pharma tariffs “Make America Manufacture Again”?

article thumbnail

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Can pharma tariffs “Make America Manufacture Again”? Credit: Department of Health Abu Dhabi.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

article thumbnail

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

Pharmaceutical Technology

Give your business an edge with our leading industry insights.

article thumbnail

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

Give your business an edge with our leading industry insights.

article thumbnail

Ethris and Thermo Fisher partner on mRNA solutions

Pharmaceutical Technology

mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. Can pharma tariffs “Make America Manufacture Again”? Editorial content is independently produced and follows the highest standards of journalistic integrity. Give your business an edge with our leading industry insights.

article thumbnail

Madrigal poised to enter European MASH market after CHMP endorsement

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.